William Strickland, MD
Neurology · Nashville, TNNPI 1306841424
Payments from drug & device makers
Across 140 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$804
- Amgen$362
- Sunovion Pharmaceuticals Inc.$278
- Sumitomo Pharma America, Inc.$217
- Pfizer$211
- AbbVie$194
- plus $886 from 21 others
What the payments were for
- Food & beverage$2,952100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 35 | $804 |
| Amgen | 19 | $362 |
| Sunovion Pharmaceuticals Inc. | 14 | $278 |
| Sumitomo Pharma America, Inc. | 12 | $217 |
| Pfizer | 11 | $211 |
| AbbVie(2 entities) | 6 | $194 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $146 |
| Biohaven Pharmaceuticals, Inc. | 2 | $87 |
| Arbor Pharmaceuticals, Inc. | 5 | $77 |
| Supernus Pharmaceuticals, Inc. | 6 | $76 |
| Kedrion Biopharma Inc. | 1 | $67 |
| Teva Pharmaceuticals USA, Inc. | 5 | $66 |
| SK Life Science, Inc. | 2 | $48 |
| AstraZeneca(2 entities) | 3 | $44 |
| Eisai Inc. | 2 | $41 |
| Biogen | 2 | $40 |
| Lundbeck LLC | 2 | $27 |
| Assertio Therapeutics, Inc. | 2 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Sonex Health, Inc. | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Aprecia Pharmaceuticals, LLC | 1 | $16 |
| GRT US Holding, Inc. | 1 | $14 |
| Boston Scientific | 1 | $13 |
| Merz North America, Inc. | 1 | $11 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMGALITY$129
- NURTEC ODT$125
- UBRELVY$125
- APTIOM$121
How this compares
$2,952 in reported general payments places this provider in the 45th percentile of 361 neurology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 507 | $7,385 |
| Pregabalin | 178 | $4,998 |
| Levetiracetam | 144 | $3,257 |
| Oxcarbazepine | 53 | $1,928 |
| CarbatrolCarbamazepine | 13 | $1,414 |
| Phenobarbital | 31 | $901 |
| Phenytoin Sodium Extended | 20 | $895 |
| Primidone | 20 | $634 |
| Carbamazepine | 14 | $604 |
| Topiramate | 42 | $394 |
| Levetiracetam ErLevetiracetam | 11 | $380 |
| Divalproex Sodium | 11 | $211 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 21 | $166 |
Paid to pharmacies, not to this prescriber.
Other neurology in Nashville
- Daniel ClaassenNashville$3.5M
- Siddharama PawateNashville$2M
- John FangNashville$1.5M
- Lealani AcostaNashville$1.4M
- Amy BrownNashville$895K
- Katherine McDonellNashville$862K
- Harold MosesNashville$778K
- Philip CharlesNashville$700K
- Shilpi MittalNashville$481K
- Francesca BagnatoNashville$378K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.